Alcami Carolinas Corporation
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 4221 Faber Place Drive, Charleston, South Carolina (SC) 29405, United States (USA)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 1000110990 · DUNS 832394733
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-02-06
- VAIDrug Quality Assurance2021-10-29
- NAIDrug Quality Assurance2018-03-15
- VAIDrug Quality Assurance2017-12-15
- NAIDrug Quality Assurance2016-05-16
- NAIDrug Quality Assurance2013-12-20
- NAIDrug Quality Assurance2013-05-17
- VAIDrug Quality Assurance2012-03-23
- NAIDrug Quality Assurance2009-06-17
Drugs this plant is listed as making
8 distinct drugs across 10 products name this site in their FDA label.
- AprepitantHeron Therapeutics, Inc.
- dantrolene sodiumEagle Pharmaceuticals, Inc.
- fosdenopterin hydrobromideSentynl Therapeutics, Inc.
- ibuprofen lysinePrasco Laboratories
- tagraxofuspStemline Therapeutics, Inc.
- triamcinolone acetonideBausch & Lomb Incorporated
- verteporfin for injectionBausch Health US LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.